1338 related articles for article (PubMed ID: 33140176)
1. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
[TBL] [Abstract][Full Text] [Related]
2. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
3. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial stewardship in the UK during the COVID-19 pandemic: a population-based cohort study and interrupted time-series analysis.
Rezel-Potts E; L'Esperance V; Gulliford MC
Br J Gen Pract; 2021 May; 71(706):e331-e338. PubMed ID: 33690150
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Oladele RO; Ettu AO; Medugu N; Habib A; Egbagbe E; Osinaike T; Makanjuola OB; Ogunbosi B; Irowa OO; Ejembi J; Uwaezuoke NS; Adeleke G; Mutiu B; Ogunsola F; Rotimi V
West Afr J Med; 2023 Sep; 40(9):962-972. PubMed ID: 37768104
[TBL] [Abstract][Full Text] [Related]
6. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
[TBL] [Abstract][Full Text] [Related]
7. A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).
Tan SH; Ng TM; Tay HL; Yap MY; Heng ST; Loo AYX; Teng CB; Lee TH
J Glob Antimicrob Resist; 2021 Mar; 24():45-47. PubMed ID: 33307276
[TBL] [Abstract][Full Text] [Related]
8. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
9. Co-infection in critically ill patients with COVID-19: an observational cohort study from England.
Baskaran V; Lawrence H; Lansbury LE; Webb K; Safavi S; Zainuddin NI; Huq T; Eggleston C; Ellis J; Thakker C; Charles B; Boyd S; Williams T; Phillips C; Redmore E; Platt S; Hamilton E; Barr A; Venyo L; Wilson P; Bewick T; Daniel P; Dark P; Jeans AR; McCanny J; Edgeworth JD; Llewelyn MJ; Schmid ML; McKeever TM; Beed M; Lim WS
J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33861190
[No Abstract] [Full Text] [Related]
10. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
11. Coinfections with Other Respiratory Pathogens among Patients with COVID-19.
Sreenath K; Batra P; Vinayaraj EV; Bhatia R; SaiKiran K; Singh V; Singh S; Verma N; Singh UB; Mohan A; Bhatnagar S; Trikha A; Guleria R; Chaudhry R
Microbiol Spectr; 2021 Sep; 9(1):e0016321. PubMed ID: 34287033
[TBL] [Abstract][Full Text] [Related]
12. Bacterial co-infections with SARS-CoV-2.
Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
[TBL] [Abstract][Full Text] [Related]
13. Using Culture Sensitivity Reports to Optimize Antimicrobial Therapy: Findings and Implications of Antimicrobial Stewardship Activity in a Hospital in Pakistan.
Altaf U; Saleem Z; Akhtar MF; Altowayan WM; Alqasoumi AA; Alshammari MS; Haseeb A; Raees F; Imam MT; Batool N; Akhtar MM; Godman B
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512049
[No Abstract] [Full Text] [Related]
14. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
[TBL] [Abstract][Full Text] [Related]
15. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial use in patients with confirmed COVID-19 infection in the Philippines: a cross-sectional study.
Dominguez RJ; Domingo-Cereno NA; Josue-Dominguez RT
Western Pac Surveill Response J; 2023; 14(2):1-8. PubMed ID: 37475781
[TBL] [Abstract][Full Text] [Related]
17. Serious bacterial infections and antibiotic prescribing in primary care: cohort study using electronic health records in the UK.
Gulliford MC; Sun X; Charlton J; Winter JR; Bunce C; Boiko O; Fox R; Little P; Moore M; Hay AD; Ashworth M;
BMJ Open; 2020 Feb; 10(2):e036975. PubMed ID: 32114481
[TBL] [Abstract][Full Text] [Related]
18. Increased antimicrobial resistance during the COVID-19 pandemic.
Lai CC; Chen SY; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2021 Apr; 57(4):106324. PubMed ID: 33746045
[TBL] [Abstract][Full Text] [Related]
19. The interface between COVID-19 and bacterial healthcare-associated infections.
O'Toole RF
Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
[TBL] [Abstract][Full Text] [Related]
20. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
Ramsamy Y; Muckart DJ; Han KS
S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
